S. Sui

The C domain of HIV-1 gp41 binds the putative cellular receptor protein P62.

M. Dierich, J. Yang, W. Wu, 1999, AIDS.

Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy

F. Lu, Z. Duan, S. Zheng, 2015, Experimental and therapeutic medicine.

Antibodies against human IFN-alpha and -beta recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45.

J. Sun, M. Dierich, J. Yang, 1999, Immunology letters.